425: Strive-Semler Merger: Cautionary Outlook & Risks

Strive, Inc. and Semler Scientific, Inc. issued a cautionary statement regarding their proposed business combination, highlighting inherent risks and uncertainties.

Summary

• This Form 425 filing by Strive, Inc. pertains to its proposed business combination with Semler Scientific, Inc.
• The communication originated from a post on X.com by Matthew Cole, CEO of Strive, Inc., on November 10, 2025.
• The document serves as a cautionary statement concerning forward-looking statements related to the merger, outlining various risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Investors and stockholders are strongly advised to review the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus once they become available.
• Strive and Semler Scientific, along with certain directors and executive officers, may be considered participants in the solicitation of proxies from Semler Scientific stockholders for the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure for a proposed business combination, primarily focusing on cautionary statements and risks associated with forward-looking information. While it mentions anticipated benefits, the extensive list of potential challenges and uncertainties creates a neutral to slightly cautious sentiment.

Positives

• The proposed transaction is expected to generate strategic and financial benefits for the combined company.
• Management of both Strive and Semler Scientific believes that expectations regarding forward-looking statements are based on reasonable assumptions within their existing knowledge of business and operations.

Risks

• Any event, change, or circumstances could arise that grants one or both companies the right to terminate the merger agreement.
• The proposed transaction may not close as expected or at all if closing conditions are not met on a timely basis.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, potentially due to issues with Bitcoin treasury strategies and digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory enforcement could adversely affect the combined company.
• The integration of the two companies might be more difficult, time-consuming, or costly than initially projected.
• The proposed transaction could be more expensive or take longer to complete than anticipated due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution.
• Customers of Strive or Semler Scientific may react adversely, or business and employee relationships could change following the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price could occur before the closing of the merger.
• Other unknown or unpredictable factors could negatively impact the results of Strive, Semler Scientific, or the combined company.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed business combination, though they acknowledge that actual results may differ materially from projections due to various risks and uncertainties. They expect to successfully integrate the combined businesses, but caution that the process could be more difficult, time-consuming, or costly than expected.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted the communication on X.com on November 10, 2025.
• Each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations.

Industry Context

This filing reflects a common practice in M&A transactions where companies issue cautionary statements to inform investors about the inherent risks and uncertainties associated with forward-looking statements and the integration process. The mention of 'Bitcoin treasury strategies and other digital assets' suggests an evolving trend in corporate finance, particularly for companies exploring alternative asset management strategies, which could be a differentiator or a source of additional risk depending on market acceptance and regulatory developments.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.
• Information about the interests of directors and executive officers of Strive and Semler Scientific and other persons who may be deemed participants in the solicitation of stockholders will be included in the Information Statement/Proxy Statement/Prospectus.

Stakeholder Impact

• Potential adverse reactions from Strive's or Semler Scientific's customers.
• Changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Shareholders face dilution risk from Strive's issuance of additional shares of its Class A common stock.

Next Steps

• Strive and Semler Scientific will file other relevant documents concerning the proposed transaction with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets